OpenClinica Releases Enhancements to Clinical Trial Software
OpenClinica, LLC, announces the availability of the latest version of its popular open source clinical trials software. The OpenClinica v3.1.3 release contains over 100 fixes and enhancements, including:
- Improved performance and stability, including 80% increase in max user load and 40% faster page turn times
- Numerous improvements to OpenClinica's internationalization/localization support
- Support for CRF version migration of individual event CRFs
- Enhanced security with strong password configuration options
- Greater reliability when entering or editing data in repeating groups
- Ability to run rules at data import and when loading data via web services
- Fixes to nested simple conditional displays in CRFs
These, and many other, advancements are the result of efforts by OpenClinica, LLC and members of the OpenClinica community. “OpenClinica community contributors have helped fuel a lot of the progress reflected in this release,” said Cal Collins, OpenClinica’s CEO. “This release is evidence that a strong open source community can drive the software to a higher quality standard.”
OpenClinica 3.1.3 Community Edition is freely available for download on the OpenClinica community website.
The company also announces that version 3.1.3 of its commercially backed OpenClinica Enterprise Edition is also now available. OpenClinica Enterprise is provided as fully validated, enhanced, and supported implementation of the open source technology, ideal for mission critical environments. This latest rendition of the OpenClinica Enterprise Edition also leverages Akamai’s global content delivery network (CDN), further accelerating the application’s performance.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Regulatory Compliance With eCOAs
April 26th 2024In the fourth and final part of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA discusses how the regulatory stance on electronic clinical outcome assessments has changed over the years and what it could look like in the future.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
